Abbott Laboratories (NYSE:ABT) announced a quarterly dividend on Friday, February 15th. Shareholders of record on Monday, April 15th will be paid a dividend of $0.14 per share on Wednesday, May 15th. This represents a $0.56 annualized dividend and a dividend yield of 1.61%.
A number of analysts have recently weighed in on ABT shares. Analysts at Jefferies Group reiterated a “buy” rating on shares of Abbott Laboratories in a research note to investors on Friday. They now have a $40.00 price target on the stock. On the ratings front, analysts at Stifel Nicolaus initiated coverage on shares of Abbott Laboratories in a research note to investors on Friday. They set a “buy” rating and a $40.00 price target on the stock. Finally, analysts at TheStreet reiterated a “hold” rating on shares of Abbott Laboratories in a research note to investors on Thursday, February 7th.
Seven analysts have rated the stock with a buy rating, fifteen have assigned a hold rating, and one has assigned a sell rating to the company. Abbott Laboratories presently has an average rating of “overweight” and a consensus target price of $35.00.
Shares of Abbott Laboratories (ABT) traded up 0.99% during mid-day trading on Friday, hitting $35.045. Abbott Laboratories (ABT) has a one year low of $26.764 and a one year high of $34.75. The stock’s 50-day moving average is currently $33.24. The company has a market cap of $55.394 billion and a P/E ratio of 9.33.
Abbott Laboratories last posted its quarterly earnings results on Wednesday, January 23rd. The company reported $1.51 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.50 by $0.01. The company had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.58 billion. During the same quarter in the prior year, the company posted $1.45 earnings per share. The company’s quarterly revenue was up 4.4% on a year-over-year basis. Abbott Laboratories has set its FY13 guidance at $1.98-2.04 EPS. On average, analysts predict that Abbott Laboratories (ABT) will post $2.01 earnings per share for the current fiscal year.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.